Fractional Flow Reserve

Read-world data showed that more patients underwent subsequent revascularization after “CT first” evaluation for chest pain vs. other functional testing strategies, researchers reported.

SAN FRANCISCO — In a real-world population of patients with ACS or chronic coronary syndrome, a strategy guided by instantaneous wave-free ratio was similarly safe as one guided by fractional flow reserve at 5 years, data show.

Boston Scientific announced the FDA clearance of its next-generation IVUS and fractional flow reserve system designed improve guidance during PCI.

Implementation of a CT angiography-derived fractional flow reserve program on a national level was associated with reduced risk for mortality and fewer downstream CV tests at 2 years, according to the results of the FISH&CHIPS study.

Danish researchers reported that CT angiography-derived fractional flow reserve was significantly prognostic of all-cause death and acute MI in patients with stable angina, especially those with high coronary calcium scores.

In statin-treated patients with CAD and elevated triglycerides, icosapent ethyl benefited coronary physiology as assessed by CT-derived fractional flow reserve compared with placebo, according to new data from the EVAPORATE trial.

Increased change in fractional flow reserve at 3-month follow-up after PCI was moderately associated with less angina and improved quality of life, researchers reported.

NEW ORLEANS — In patients with stable CAD, use of CT-derived fractional flow reserve with on-site machine learning reduced invasive coronary angiography in those who did not need it, but did not improve other outcomes, researchers reported.

The American Heart Association Scientific Sessions were held Nov. 5 to 7 in Chicago, the first time they were conducted in-person since 2019.

Even in the COVID-19 era, atherosclerotic CVD remains the leading cause of death worldwide.